Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
8950.0000 -212.00 (-2.31%)
NSE Oct 23, 2026 15:31 PM
Volume: 620.3K
 

8950.00
-2.31%
Deven Choksey
We expect the company to grow its Revenue/EBITDA/PAT at a CAGR of 15.3% / 20% / 18.2% for the period of FY26-FY28.
Divi's Laboratories .. has an average target of 7062.83 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended